Biotechnology – The BioChain
SECTORS · BIOTECHNOLOGY

A trusted data layer for biotech, from discovery to commercial scale.

Biotech companies generate years of data across discovery, translational research, process development and commercial manufacturing. That data needs to remain coherent, defensible and verifiable — through partner changes, platform changes, scale-up changes and regulator scrutiny.

Where biotech audit trails actually break.

Most biotech data lives across fragmented systems — one for discovery, another for translational research, another again for process development and commercial manufacturing. Each transition between them is a place where provenance can quietly break: a spreadsheet exported, a system migrated, a partner change that leaves a gap in the record.

The BioChain closes those gaps by anchoring integrity to the data itself rather than to whichever system currently holds it, so the record survives every transition intact.

Nine capabilities, one continuous record.

01
Continuous provenance
Data lineage preserved across every stage of the development lifecycle.
02
Bioprocessing batch records
Batch, equipment, environment and personnel records linked into a tamper-evident chain.
03
Partner-ready evidence
Defensible records for investors, partners, regulators and acquirers.
04
API integration
Works alongside existing LIMS, ELN, MES and quality systems — no rip-and-replace.
05
Laboratory and translational data integrity
Source-anchored records from the earliest discovery-stage experiments through to translational handover.
06
Bioprocessing and manufacturing batch records
A single tamper-evident chain spanning process development through commercial-scale manufacturing.
07
Investor and partner due diligence readiness
Years of development data preserved with provenance intact, ready to withstand scrutiny during a raise or a partnership discussion.
08
M&A and tech-transfer scenarios
Defensible records that survive platform and ownership changes intact — provenance that does not depend on who currently holds the data.
09
Commercial scale-up validation
Continuous data lineage from discovery through commercial scale — unbroken provenance even as systems, sites and personnel change.

Why biotechs choose a Private BioChain.

Provenance that only exists inside a shared system stops being useful the moment a partner, platform or ownership change moves your data elsewhere. A Private BioChain is a dedicated environment for your organisation alone — deployed within your own infrastructure or a private cloud — so the record of your development history stays intact and defensible through exactly the transitions that break most audit trails.

Wherever evidence must be trusted across systems.

Public health, agritech, food safety, environmental research — if your work depends on biological data integrity, we should talk.